CE Brands Reports First Quarter 2022 Results and Additional Lockup of Shares

Written by Customer Service on August 25, 2021. Posted in Earnings Releases And Operating Results.

VICTORIA, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) — CE Brands Inc. (TSXV: CEBI; CEBI.WT) (“CE Brands”), a data-driven consumer-electronics company, today announced its financial results for the three-month period ended June 30, 2021 (“Q1 2022”). Currency amounts are in Canadian dollars unless otherwise noted. Further, CE Brands announces the lockup of an additional 1,555,000 shares from early-stage investors in eBuyNow eCommerce Ltd. prior to the RTO (as defined below). The lockup is a 12 month voluntary lockup agreement. Q1 2021 Highlights Total revenue decreased 56% in Q1 2022 compared to Q1 2021. The decrease in revenue was primarily attributable to constrained working capital within the quarter, prior to the RTO, which resulted in the inability to procure inventory for sale. Gross profit decreased by 84% in...

VAALCO Announces Binding Letter of Intent for FSO at Etame

Written by Customer Service on August 25, 2021. Posted in Public Companies.

HOUSTON, Aug. 25, 2021 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) (“VAALCO” or the “Company”) today announced that its affiliate VAALCO Gabon, SA (“VAALCO Gabon”) has signed a binding letter of intent (“LOI”) with World Carrier Offshore Services Corp. (“World Carrier”) to provide and operate a Floating Storage and Offloading (“FSO”) unit at VAALCO’s Etame Marin field offshore Gabon for up to eight years with additional option periods available upon the expiration of the current Floating Production, Storage and Offloading (“FPSO”) contract in September 2022. The non-binding LOI with Omni Offshore Terminals Pte Ltd, which VAALCO announced in April of this year, expired without any mutually agreeable contract being reached. Key Highlights Signed a binding LOI with World Carrier to enter into a Bareboat Contract...

EDAP Reports Second Quarter 2021 Results and Provides Operational Update

Written by Customer Service on August 25, 2021. Posted in Public Companies.

Total revenue for the first half 2021 of EUR 20.7 million (USD $24.8 million) increased 22.5% over the same period of the prior year Net income was EUR 0.4 million (USD 0.4 million), or EUR 0.01 per diluted share, for the first half of 2021 Cash balance of EUR 45 million (USD $53.3 million) as of June 30, 2021 Second quarter U.S. HIFU treatment volumes increased 79% over the comparable period in 2020; strong leading indicator of Focal One adoption CMS Advisory Panel on Hospital Outpatient Payment (HOP panel), at its summer meeting, unanimously recommended increasing reimbursement for HIFU prostate ablation to APC Level 6 in 2022 from Level 5 currently Company to host a conference call tomorrow, August 26, at 8:30 am ET LYON, France, August 25, 2021 — EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based...

CloudMD Reports Record Revenue of $15.7 Million in Second Quarter 2021; 9% Quarter Over Quarter Organic Growth

Written by Customer Service on August 25, 2021. Posted in Earnings Releases And Operating Results.

Record Q2 2021 revenue of $15.7 million; an increase of 461% compared to Q2 2020. Closed the acquisitions of Aspiria, Rxi, VisionPros and Oncidium in Q2 2021, adding $96 million of annual revenue. Launch of new Complete Health Platform with national client with over 10,000 employees. Complete Health Platform gains momentum with enterprise clients; increase of over 260,000 employees, driving growth in Enterprise Health Solutions and Digital Health Services. Strong financial expectations with annualized revenue run rate exceeding $140 million and positive Adjusted EBITDA1 in Q3 2021. VANCOUVER, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology company revolutionizing the delivery of care, announced...

America First Multifamily Investors, L.P. Extends Maturity of $50 Million Line of Credit

Written by Customer Service on August 25, 2021. Posted in Public Companies.

OMAHA, Neb., Aug. 25, 2021 (GLOBE NEWSWIRE) — On August 23, 2021, America First Multifamily Investors, L.P. (NASDAQ: ATAX) (the “Partnership”) entered into an Amended and Restated Credit Agreement (the “Amended Credit Agreement”) with Bankers Trust Company (“Bankers Trust”) for a secured non-operating line of credit (“Non-operating LOC”) with a maximum commitment of $50 million. The Amended Credit Agreement modifies certain provisions of the Partnership’s previous Credit Agreement with Bankers Trust dated May 14, 2015, as amended, including extension of the maturity date to June 30, 2023, and provides a first priority security interest in a custody account that will contain the Partnership’s investments purchased with advances on the Non-operating LOC. The Partnership also entered into a new Revolving Note which bears interest...

CVR Partners Announces Coffeyville Turnaround Deferral

Written by Customer Service on August 25, 2021. Posted in Public Companies.

SUGAR LAND, Texas, Aug. 25, 2021 (GLOBE NEWSWIRE) — CVR Partners, LP (“CVR Partners” or the “Partnership”) (NYSE: UAN) today announced that it currently intends to defer the scheduled turnaround at its Coffeyville, Kansas, nitrogen fertilizer facility from October 2021 to the third quarter of 2022. CVR Partners now expects its total forecasted turnaround spending for 2021 of approximately $8 million to $10 million of expense for the Coffeyville facility to be spent in 2022, which will be in addition to the planned 2022 turnaround for the Partnership’s East Dubuque nitrogen fertilizer facility. “The health and safety of our employees, contractors and communities remains our critical priority,” said Mark Pytosh, President and Chief Executive Officer of CVR Partners’ general partner. “Between the recent spike in COVID-19 cases and...

ABM Industries Announces Definitive Agreement to Acquire Able Services

Written by Customer Service on August 25, 2021. Posted in Mergers And Acquisitions.

—Strategic Acquisition Adds $1.1 Billion in Engineering and Janitorial Services Revenues——Increases ABM’s Engineering and Technical Services Revenues to ≈ $2 Billion, Expanding Sustainability & Energy-Efficiency Offerings— —Strengthens Janitorial Services Business and Provides Opportunities to Expand EnhancedClean™ Across Broader Footprint——Operating Synergies of Approximately $30 Million to $40 Million Identified——Transaction Expected to be Accretive to Adjusted Earnings Per Share Immediately After Closing— —Conference call to be held today at 6:15 PM ET— NEW YORK, Aug. 25, 2021 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, announced today that it has reached a definitive agreement to acquire Able Services, a leading facilities services company headquartered in San Francisco, in a cash transaction...

Ascendis Pharma A/S Reports Second Quarter 2021 Financial Results

Written by Customer Service on August 25, 2021. Posted in Earnings Releases And Operating Results.

– Announced U.S. Food and Drug Administration Approval of SKYTROFA® (lonapegsomatropin-tcgd), the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency – – Exceeded target enrollment in Phase 3 PaTHway Trial for TransCon PTH (palopegteriparatide) in adults with hypoparathyroidism (HP); top-line results expected in Q1 2022 – – Initiated combination therapy arm in transcendIT-101; TransCon TLR7/8 Agonist used in combination with a check point inhibitor (CPI) – – Conference call today at 4:30 p.m. Eastern Time – COPENHAGEN, Denmark, Aug. 25, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to potentially create new treatments that make a meaningful difference in patients’ lives, today announced financial results for the second...

Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors

Written by Customer Service on August 25, 2021. Posted in Public Companies.

BERKELEY, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that it has appointed Nancy Whiting, Pharm.D., to its board of directors. Dr. Whiting brings over 17 years of biotechnology industry expertise in drug and portfolio development, as well as significant strategic leadership experience. “I am delighted to welcome Nancy to our board of directors,” said Rachel Haurwitz, Ph.D., Caribou’s president and chief executive officer. “She has significant experience in all phases of drug development and commercialization with particular expertise in oncology, which is highly relevant to Caribou as we advance our pipeline of chRDNA-edited allogeneic cell therapies for the potential treatment of a variety of hematologic...

INmune Bio, Inc. Announces Biomarker Data Demonstrating that the First Patient Treated with its NK Cell Priming “Pseudokine”, INKmune™, Successfully Produced Memory-Like NK Cells

Written by Customer Service on August 25, 2021. Posted in Public Companies.

First positive clinical confirmation of in vivo NK response, mirroring in vitro data Boca Raton, FL, Aug. 25, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced today that the first patient who received INKmune™ as a potential treatment for high-risk myelodysplastic syndrome (MDS) has successfully shown the NK activation and functional differentiation predicted by previously published in vitro experiments. NK cells need multiple activating signals to progress from a resting state to the triggering of cytolysis and cytokine secretion. INmune Bio has studied these pathways extensively and demonstrated that binding of NK cells with INKmune™ provides multiple activating...

Day: August 25, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice